The application of mental imagery as a therapeutic intervention for Parkinson’s disease is gaining attention, with Kahramanmaras Sutcu Imam University recruiting participants for a clinical trial. This study investigates how mental imagery training can impact gait and balance issues commonly faced by individuals living with Parkinson’s disease.
Published: October 5, 2025
In this article:
- What changed?
- How is the study designed?
- Why is this significant?
- FAQs
- Conclusion
- Disclaimer
- Full announcement details
What changed?
On October 5, 2025, Kahramanmaras Sutcu Imam University officially announced its active recruitment for a clinical trial evaluating mental imagery training as a potential advanced intervention in Parkinson’s disease management. The trial focuses on addressing impaired gait and balance, two critical mobility issues affecting individuals with this neurodegenerative disorder. This study could pave the way for novel therapeutic strategies, possibly reducing the dependence on invasive treatment options.
How is the study designed?
The intervention protocol
The research employs a Mental Imagery Application Protocol as its primary intervention. This technique encourages participants to mentally visualize movements and activities related to walking and balancing before executing them physically. Researchers hypothesize that repeated imagery training could improve neural pathways involved in motor control.
Conditions addressed
The study specifically targets Parkinson’s disease patients dealing with gait instability and balance disorders. Both have a significant impact on quality of life and often lead to falls and increased dependency.
Research oversight
The study is sponsored by Kahramanmaras Sutcu Imam University. Its regulatory framework adheres to ClinicalTrials.gov guidance, ensuring ethical practices and compliance standards are strictly followed throughout the process.
Why is this significant?
Parkinson’s disease affects millions of people worldwide. Despite ongoing advancements in treatment, motor symptoms like impaired gait and balance remain challenging to manage. This study explores a non-invasive, cost-effective technique that could complement existing therapies or offer new solutions for those who respond poorly to medication-based treatments.
Moreover, mental imagery studies align with cognitive-based approaches, showcasing their potential for long-term impact without the need for devices or surgery. Results from this clinical trial may set a precedent for broader adoption of cognitive therapies within neurological treatment protocols.
FAQs
- What is mental imagery training?
Mental imagery involves mentally rehearsing a planned activity before physically performing it. This technique aims to engage neural pathways involved in the activity. - Who is eligible to participate?
Patients with Parkinson’s disease who experience gait and balance issues are eligible. Further inclusion criteria may be outlined by the research team. - Is this intervention a medical device?
No, this is a cognitive therapy, not a physical medical device. It uses mental techniques to impact motor function. - Where can participants sign up?
Eligible participants will need to contact Kahramanmaras Sutcu Imam University or visit the ClinicalTrials.gov listing for details.
Conclusion
This clinical trial shines a light on mental imagery training as a promising non-invasive intervention for Parkinson’s disease management. As recruitment begins, stakeholders in neurology and physical rehabilitation should watch closely for outcomes that could reshape existing therapeutic pathways.
Disclaimer
The information provided is strictly for healthcare professionals and researchers. It does not constitute legal advice or medical endorsement. Readers should consult official trial documents or regulatory guidelines before making decisions related to this study.
For full information about the announcement, see the link below.
https://clinicaltrials.gov/study/NCT07193355?term=medical+device